TrialHepatology (Baltimore, Md.)2021

Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Children With Chronic HCV: Part 2 of the DORA Study.

Maureen M Jonas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.